Related Experiment Videos
Structures of new 18-membered macrolides FD-891 and FD-892
M Seki-Asano1, Y Tsuchida, K Hanada
1Dept. of Research Center, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
The Journal of Antibiotics
|November 1, 1994
Abstract:
Structures of FD-891 and FD-892 were determined by extensive NMR spectral analysis as shown in Fig. 1. They belong to such 18-membered macrolides as concanamycins and virustomycin.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Patient-specific dose estimation considering subject thickness with an RGB-D camera: A phantom study.
Radiography (London, England : 1995)·2025
Development of a limiter-like Langmuir probe system for the Q-shu university experiment with steady-state spherical tokamak (QUEST) all-metal device.
The Review of scientific instruments·2025
Conceptual design of a heavy ion beam probe for the QUEST spherical tokamak.
The Review of scientific instruments·2022
Adaptive Capon beamforming for lensless electron cyclotron emission imaging with high spatial resolution.
The Review of scientific instruments·2022
Comprehensive derivatization of thiostrepton via heterologous expression.
The Journal of antibiotics·2026
Luteoagmacins A and B, new antimicrobial agmatine derivatives from a hot spring water-derived Luteococcus sp.
The Journal of antibiotics·2026
A N-methylated antimicrobial peptide targets the fructose transporter FruA of Staphylococcus aureus.
The Journal of antibiotics·2026
Discovery of new α-pyrone derivative with α-glucosidase inhibitory activity from the fungus Acremonium persicinum.
The Journal of antibiotics·2026
Novel Benzofuran Derivatives as SARM1 Inhibitors for Treating Axonal Degeneration.
ACS medicinal chemistry letters·2026
Novel Compounds as SMARCA2 Inhibitors for Treating Non-small Cell Lung Cancer.
ACS medicinal chemistry letters·2026
Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.
ACS medicinal chemistry letters·2026
Structural Preferences and ADMET Regulation of Fluorinated Small-Molecule Drugs.
ACS medicinal chemistry letters·2026